| Basics |
Celcuity Inc. Common Stock
Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
|
| IPO Date: |
September 20, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$4.89B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 2.97%
|
| Avg Daily Range (30 D): |
$2.31 | 2.72%
|
| Avg Daily Range (90 D): |
$2.03 | 3.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.13M |
| Avg Daily Volume (30 D): |
.75M |
| Avg Daily Volume (90 D): |
.99M |
| Trade Size |
| Avg Trade Size (Sh.): |
65 |
| Avg Trade Size (Sh.) (30 D): |
48 |
| Avg Trade Size (Sh.) (90 D): |
57 |
| Institutional Trades |
| Total Inst.Trades: |
727 |
| Avg Inst. Trade: |
$2.83M |
| Avg Inst. Trade (30 D): |
$4.8M |
| Avg Inst. Trade (90 D): |
$3.39M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.11M |
| Avg Closing Trade (30 D): |
$6.9M |
| Avg Closing Trade (90 D): |
$5.67M |
| Avg Closing Volume: |
122.6K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-3.68
|
$-.92
|
$-1.04
|
|
Diluted EPS
|
$-3.68
|
$-.92
|
$-1.04
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -162.72M
|
$ -43.8M
|
$ -45.27M
|
|
Operating Income / Loss
|
$ -159.42M
|
$ -42.85M
|
$ -44.01M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 61.65M
|
$ 27.9M
|
$ 29.88M
|
|
PE Ratio
|
|
|
|
|
|
|
